发明名称 |
PARAOXONASE 1 ENZYMATIC ACTIVITY, A RISK PREDICTOR FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS |
摘要 |
Provided herein are methods for assessing the risk a subject or patient without significant evidence of cardiovascular disease has of experiencing a major adverse cardiac event or requiring revascularization near term. Also provided are methods of determining whether a subject who has experienced a major adverse cardiac event is at risk of experiencing a recurrent major adverse cardiac event near term. The present methods comprise determining the levels of paraoxonase 1 enzymatic activity in the blood, serum, plasma, or any combination of said bodily fluids in the subject. |
申请公布号 |
EP2254470(A1) |
申请公布日期 |
2010.12.01 |
申请号 |
EP20090712781 |
申请日期 |
2009.02.20 |
申请人 |
THE CLEVELAND CLINIC FOUNDATION |
发明人 |
HAZEN, STANLEY, L.;NICHOLLS, STEPHEN, JAMES |
分类号 |
A61B5/145;C12Q1/34;C12Q1/44 |
主分类号 |
A61B5/145 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|